Short term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse

被引:15
作者
Bray, BJ
Brennan, NJ
Perry, NB
Menkes, DB
Rosengren, RJ
机构
[1] Univ Otago, Sch Med, Dept Pharmacol, Dunedin, New Zealand
[2] Univ Otago, New Zealand Inst Crop & Food Res, Dunedin, New Zealand
[3] Univ Otago, Dept Psychol Med, Dunedin, New Zealand
关键词
St. John's wort; hypericum perforatum; hypericin; hyperforin; CYP3A; CYP2E1; CYP1A2;
D O I
10.1016/S0024-3205(01)01499-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This investigation was designed to determine whether St. John's wort (SJW)(435 mg/kg/d), a readily available anti depressant, or its purported active constituents hypericin (I mg/kg/d) and hyperforin (10 mg/kg/d) were able to induce various hepatic cytochrome P450 (CYP450) isoforms. SJW, hypericin and hyperforin were administered to male Swiss Webster mice for four consecutive days and hepatic microsomes were prepared on day 5. None of the three treatments resulted in a statistical change in total hepatic CYP450 (SJW treated 0.95 +/- 0.09 nmol/mg vs control 1.09 +/- 0.14 nmol/mg). Furthermore, the catalytic activities of CYP1A2, CYP2E1 and CYP3A were unchanged from control following all three treatments as determined by ethoxyresorufin O-deethylation, p-nitrophenol hydroxylation and erythromycin N-demethylation respectively. Additionally, western immunoblotting demonstrated that there was no significant change in the polypeptide levels of any of the three isoforms. These results indicate that four days of treatment with moderate to high doses of SJW, hyperforin or hypericin fails to induce these CYP450 isoforms in the male Swiss Webster mouse. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1325 / 1335
页数:11
相关论文
共 32 条
[1]  
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
[2]   Hyperforin as a possible antidepressant component of hypericum extracts [J].
Chatterjee, SS ;
Bhattacharya, SK ;
Wonnemann, M ;
Singer, A ;
Müller, WE .
LIFE SCIENCES, 1998, 63 (06) :499-510
[3]  
Clevenbergh P, 1999, AIDS REV, V1, P156
[4]   St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 [J].
Dürr, D ;
Stieger, B ;
Kullak-Ublick, GA ;
Rentsch, KM ;
Steinert, HC ;
Meier, PJ ;
Fattinger, K .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) :598-604
[5]   Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. [J].
Erdelmeier, CAJ .
PHARMACOPSYCHIATRY, 1998, 31 :2-6
[6]   Second thoughts about safety of St John's wort [J].
Ernst, E .
LANCET, 1999, 354 (9195) :2014-2016
[7]   Herb-drug interactions [J].
Fugh-Berman, A .
LANCET, 2000, 355 (9198) :134-138
[8]  
Guengerich F.P., 1989, Principles and methods of toxicology, P777
[9]  
HOLZL J, 1987, DTSCH APOTH ZTG, V127, P1227
[10]  
Josey ES, 1999, INT J CLIN PHARM TH, V37, P111